endogene.bio
non-invasive uterine disease insights
- B2B
About endogene.bio
Developing molecular tools using menstrual blood to provide detailed uterine disease biology, improving diagnosis and treatment of endometriosis.
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- paris, Île-de-France, France
- Founded
- 2022
- Revenue
- $4.8M – $37.9MTamtam estimate
- Website
- endogene.bio
endogene.bio at a glance
endogene.bio is a B2B company in the Biotechnology Research industry, headquartered in paris, Île-de-France, France.
endogene.bio was founded in 2022.
endogene.bio has 11–50 employees.
endogene.bio's revenue is $4.8M – $37.9M (Tamtam estimate).
Selling to companies like endogene.bio?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies